Earnings Feed
Start Free
Hinge Health, Inc.·4

Feb 19, 7:12 PM ET

Robinson Elliott 4

Research Summary

AI-generated summary

Updated

Hinge Health (HNGE) Robinson Elliott Sells Shares

What Happened

  • Robinson Elliott, a partner at Bessemer Venture Partners and reported 10% owner, filed a Form 4 disclosing sales of Hinge Health (HNGE) Class A stock by Bessemer-managed funds on Feb 17–18, 2026. The filing shows the sales were effected by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P., not Elliott personally.
  • On Feb 17 the Bessemer Funds sold 46,276 and 43,440 shares (total 89,716) at a weighted average price of $39.929 (prices ranged $39.50–$40.31). On Feb 18 they sold 48,353 and 45,390 shares (total 93,743) at a weighted average price of $40.358 (prices ranged $39.535–$40.855). Combined sales ≈ 183,459 shares for roughly $7.36 million. Elliott disclaims direct beneficial ownership of the fund-held shares, noting only an indirect, passive pecuniary interest.

Key Details

  • Transaction dates and prices: Feb 17, 2026 — weighted avg $39.929 (range $39.50–$40.31); Feb 18, 2026 — weighted avg $40.358 (range $39.535–$40.855).
  • Shares sold: 89,716 on Feb 17; 93,743 on Feb 18; total ≈ 183,459 shares; approximate proceeds ≈ $7.36M.
  • Shares owned after transaction: The filing does not attribute these shares as Elliott’s direct holdings; he disclaims beneficial ownership except for any indirect pecuniary interest.
  • Footnotes: Reporter (Elliott) is a partner at Bessemer and states the sales were by the Bessemer Funds; he offers to provide a per-price breakdown on request. This report does not assert Elliott personally sold the shares.
  • Timeliness: Reported Feb 19, 2026 covering Feb 17–18 trades — appears timely (filed within the Form 4 filing window).

Context

  • These are institutional fund sales by Bessemer-managed vehicles, disclosed because Elliott is a partner with an indirect economic interest. Such sales reflect fund-level portfolio activity rather than a direct insider sale by an executive; they should be interpreted accordingly. Purchases generally carry stronger signals about insider conviction; this filing documents routine fund liquidation.